Viewing Study NCT01020305

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:13 AM
Ignite Modification Date: 2026-02-06 @ 2:45 AM
Study NCT ID: NCT01020305
Status: TERMINATED
Last Update Posted: 2014-10-13
First Post: 2009-10-30
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer
Sponsor: Sandy Srinivas
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
None Prostatic Neoplasms View
None Castrate-resistant Prostate Cancer (CRPC) View
None Androgen-insensitive Prostate Cancer View
None Hormone-refractory Prostate Cancer View
None Metastatic Disease View
Keywords: